Last reviewed · How we verify
NCT05835557
Physiological Outcomes of High-intensity Interval Training With Post-exercise Blood Flow Restriction
NA trial testing BFR-ST in Exercise Performance in 40 participants. Completed in 30 September 2024.
30 September 2024
Quick facts
| Lead sponsor | Nanyang Technological University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | other |
| Enrollment | 40 |
| Start date | 1 July 2023 |
| Primary completion | 30 September 2024 |
| Estimated completion | 30 September 2024 |
| Sites | 1 location across Singapore |
Drugs / interventions tested
- BFR-ST
- ST
Conditions studied
- Exercise Performance — all drugs for Exercise Performance →
Sponsor
Nanyang Technological University
Who can join
Adults 18 to 40, male only, with Exercise Performance. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This research study revolves around the physiological outcomes of using post-exercise blood flow restriction (BFR) with high intensity short interval training (ST) The main aims of this study are to compare (i) aerobic performance outcomes, and (ii) anaerobic and muscular performance outcomes - between 2 groups of participants after either undergoing 3 weeks of ST + post-exercise BFR (BFR-ST) or traditional ST.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05835557
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Exercise Performance
Currently open trials in the same condition.
- NCT07252778 — Effect of a Short-term Multi-strain Probiotic Supplementation in Endurance Athletes · Phase 2, PHASE3 · recruiting
- NCT06894875 — Effects of Lentil Protein Hydrolysate on Blood Pressure Control, Vascular Function and Exercise Performance · NA · recruiting
- NCT07024940 — Short-term Effects of Caffeine and a Multi-ingredient Pre-workout on Exercise Performance · NA · recruiting
- NCT06672952 — Dose-Response Impact of Glucosyl-Hesperidin (CitraPeak) on Exercise Performance, Blood Flow, Stress, Cognition, and Othe · NA · recruiting
- NCT07481578 — Impact of Training Load on the Gut miCrobiome And Its Relation to exeRcise Performance, mUscle Phenotype, and markerS of · NA · recruiting
Other Nanyang Technological University trials
Trials by the same sponsor.
- NCT07425951 — Building Cognitive Behavioural Skills With StoryBooks to Reduce Emotional Difficulties in Kindergarten Years · NA · recruiting
- NCT07497711 — Virtual Menstrual Pain Approaches in Females · Phase 2, PHASE3 · not yet recruiting
- NCT07288892 — Effects of Pulsed Electromagnetic Field Therapy on Sport Performance and Recovery · NA · recruiting
- NCT06991764 — Investigating the Effectiveness of a 2-week Novel Non-invasive Brain Stimulation Technique on Cognitive Outcomes in Heal · NA · not yet recruiting
- NCT06732297 — Stronger Families Through Art Therapy: A Mixed Methods Programme Evaluation Study · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05835557 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Nanyang Technological University
- Last refreshed: 13 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05835557.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing